Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT01610375




Registration number
NCT01610375
Ethics application status
Date submitted
22/03/2012
Date registered
4/06/2012
Date last updated
29/08/2019

Titles & IDs
Public title
Telephone Follow-up After Treatment for Endometrial Cancer
Scientific title
Telephone Follow-up After Treatment for Endometrial Cancer.
Secondary ID [1] 0 0
TEACUP
Universal Trial Number (UTN)
Trial acronym
TEACUP
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Endometrial Cancer 0 0
Condition category
Condition code
Cancer 0 0 0 0
Womb (Uterine or endometrial cancer)

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - Telephone Follow-up

Other: Telephone Follow-up - Women previously treated for endometrial cancer will be recruited into one study group and continue to be followed per the current routine clinic follow-up. However, an additional program (telephone follow-up) will be offered in parallel to the current clinic follow-up. Outcomes obtained from the telephone follow-up will be compared with the current clinical assessment.


Other interventions: Telephone Follow-up
This is a non-randomised observational study to assess the value of a symptom checklist to detect recurrence in women with endometrial cancer. Women will be telephoned using an evidence-based symptom checklist in parallel to the standard clinic-based follow-up. The researcher will call the participants 2 to 5 days prior to their scheduled clinic review dates to enquire about the presence of symptoms which may be indicative of disease recurrence. In addition, the researcher will also enquire about the participants' wellbeing and provide standard lifestyle resource on physical activity, diet and other lifestyle behaviours and supportive care when needed.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Sensitivity, specificity and overall accuracy of the telephone follow-up compared to clinic-based follow-up and patients' satisfaction.
Timepoint [1] 0 0
12 months
Secondary outcome [1] 0 0
Changes in lifestyle behaviours and quality of life overtime.
Timepoint [1] 0 0
12 months

Eligibility
Key inclusion criteria
To be eligible for this pilot study, the patient must;

- Have completed primary treatment for endometrial cancer

- Be recurrence-free

- In the first to third year after treatment

- Be able to read and understand English

- Must have access to a telephone and adequate hearing

- Participants must be willing to complete questionnaire on satisfaction with nurse and
clinic follow-up
Minimum age
No limit
Maximum age
No limit
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
- Patients with disease recurrent or relapse

- Patients with metastatic disease presentation

Study design
Purpose of the study
Health Services Research
Allocation to intervention
N/A
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/06/2012
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/12/2018
Sample size
Target
Accrual to date
Final
149
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 0 0
Royal Brisbane and Women's Hospital - Herston
Recruitment postcode(s) [1] 0 0
4029 - Herston

Funding & Sponsors
Primary sponsor type
Other
Name
Queensland Centre for Gynaecological Cancer
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The aim of this study is to investigate the feasibility, safety and accuracy of a telephone
follow-up for women previously treatment for endometrial cancer.

To achieve this aim, potentially eligible women attending the Queensland Centre for
Gynaecological Cancer (QCGC) outpatient clinic for review following previous treatment for
endometrial cancer will be recruited by this study. The study aims to recruit all new
patients as well as all patients who return to QCGC for their follow-up and who had treatment
within the previous 2 years.

The proposed project will involve generation of an evidence-based checklist of signs and
symptoms of disease recurrence from a thorough literature review. The generated symptom
checklist will be pilot tested and the refined symptom checklist will be used to follow study
participants over a period of 12 months.

During the follow-up period, the basic standard of follow-up after primary treatment for
endometrial cancer at the QCGC, Royal Brisbane and Women's Hospital (RBWH)will not be
altered; however, the study participants will be interview via telephone 2 to 5 days prior to
their scheduled review dates.

The main outcome measure will be the estimated recurrence rate as derived from the telephone
assessment and this will be compared to the clinically detected recurrences as recorded in
patients' medical files.

It is hypothesized, that the telephone follow-up will identify 90% of all recurrences
correctly that are later confirmed during the clinical follow-up.

In addition to the main outcome, we will also assess patients' satisfaction with each of the
follow-up programs, whether or not lifestyle behaviours were queried and support offered to
improve wellbeing.
Trial website
https://clinicaltrials.gov/ct2/show/NCT01610375
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Andreas Obermair, MD FRANZCOG CGO
Address 0 0
Queensland Center for Gynecological Cancer
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT01610375